Rare diseases, exceptional people: Filippo Buccella has battled for 25 years to improve care for children with Duchenne Muscular Dystrophy (DMD ... Doctors offered little hope for his future ...

Columnist Shalom Lim shares how his business, Rebirth Ensemble, will allow him to pursue visual arts and support artists with disabilities.

Phase 2 results with Wave Life Sciences' Duchenne muscular dystrophy candidate WVE-N531 pushed the company's share price to its highest level in a year and could lead to discussions with ...

Kuntz, MD, was a fellow about 45 years ago, there were few more devastating diagnoses than Duchenne muscular dystrophy (DMD).

Opens in a new tab or window SAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, missed its primary endpoint but differences ...

28, 2024 — Using state-of-the-art technology ... lead to new treatments for people with Duchenne ... New Gene Therapy for Muscular Dystrophy Offers Hope July 17, 2024 — A new gene therapy ...

VIJAYAWADA: Founded by Sobharani Sunkara in 2019, the Amaravathi Rare Diseases Organisation (ARDO) has emerged as a beacon of hope for individuals suffering from muscular dystrophy (MD ...

The $514,000 DOD award will be used to study the efficacy of gene editors in the treatment of Duchenne Muscular Dystrophy.

We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Wave Life Sciences (NASDAQ:WVE) stands against other biggest ...

Zinc supplementation showed limited benefits in improving muscle health and hydration in boys with DMD. Nearly 30% of participants had low zinc levels initially, with slight improvement post ...